Compounding pharmacy market projected to hit 31B by 2034, personalised medicine push
Posted by elle_z in Research & News - 1 points, 2 comments.
BioSpace ran a piece projecting the US compounding pharmacy market will hit USD 31.77 billion by 2034, with personalised medicine demand cited as the main accelerant. It mentions things like multi-state licensing expansions and the broader shift toward individualised dosing and formulations.
My take is the growth number itself is not surprising. Once GLP-1s exploded off-label, and more people started asking about compounded peptides, BHRT, and custom hormone work, the whole industry basically had to scale up to keep up. What I am more curious about is the regulatory side. The FDA has been cracking down on mass compounding for things like semaglutide, so how do you square a 31B projection with a tightening legal environment?
Anyone here actually working in or following compounding pharmacy news closely? Wondering if the big growth is coming from legit personalised prescriptions, or if it is still mostly the grey-area stuff driving the numbers 😅
Comments
- honestgreg: Honestly the projection tracks with what I am seeing on my end, to be fair I only deal with it as a patient/customer so take it with a grain of salt. The BHRT side and custom thyroid stuff seems to be carrying a lot of that growth, not just GLP-1s. My guess is most of the actual dollars are legit 503A and 503B work, sterile hormone preparations and provider-written scripts for things that big pharma has no interest in making anymore. The grey area definitely inflated the numbers during the sema
- elle_z: Yeah the BHRT angle makes sense, i hadn't thought about that one carrying so much weight tbh. Big pharma really has stepped back from a lot of custom hormone stuff, so 503A/B outfits are filling that gap whether the FDA likes it or not 😅 The bit about grey area revenue not sticking is what gets me too. Like how much of that 31B is real sustained demand vs the compounding frenzy that came with the semaglutide shortage and will dry up. You reckon the legit personalised side is enough to carry th
Community discussion - research and educational context only. Not medical advice.